[Evaluation of Elarzone-Dausse phlebology].
D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010653:Phenylbutazone / Q000037:antagonists & inhibitors / Q000627:therapeutic use*; D010689:Phlebitis / Q000188:drug therapy; D012594:Scleroderma, Localized / Q000188:drug therapy; D012867:Skin / Q000098:blood supply; D012871:Skin Diseases / Q000188:drug therapy*; D012883:Skin Ulcer / Q000188:drug therapy; D014648:Varicose Veins / Q000601:surgery; D014652:Vascular Diseases / Q000188:drug therapy*
D010653:Phenylbutazone
Essai d'Elarzone-Dausse en phlébologie